UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
☒ |
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended September 29, 2017
Or
☐ |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission File No. 001-35083
Novanta Inc.
(Exact name of registrant as specified in its charter)
New Brunswick, Canada |
|
98-0110412 |
(State or other jurisdiction of incorporation or organization) |
|
(I.R.S. Employer Identification No.) |
|
|
|
125 Middlesex Turnpike Bedford, Massachusetts, USA |
|
01730 |
(Address of principal executive offices) |
|
(Zip Code) |
(781) 266-5700
(Registrant’s telephone number, including area code)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (Section 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer |
|
☐ |
|
Accelerated filer |
|
☒ |
|
|
|
|
|||
Non-accelerated filer |
|
☐ (Do not check if a smaller reporting company) |
|
Smaller reporting company |
|
☐ |
|
|
|
|
|
|
|
|
|
|
|
Emerging growth company |
|
☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
As of October 27, 2017, there were 34,592,138 of the Registrant’s common shares, no par value, issued and outstanding.
NOVANTA INC.
TABLE OF CONTENTS
Item No. |
|
|
Page |
||
|
|
||||
|
1 |
||||
|
|
|
|||
ITEM 1. |
|
|
1 |
||
|
|
|
|||
|
|
|
1 |
||
|
|
|
|||
|
|
|
2 |
||
|
|
|
|||
|
|
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (unaudited) |
|
3 |
|
|
|
|
|||
|
|
|
4 |
||
|
|
|
|||
|
|
|
5 |
||
|
|
|
|||
ITEM 2. |
|
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS |
|
27 |
|
|
|
|
|||
ITEM 3. |
|
|
40 |
||
|
|
|
|||
ITEM 4. |
|
|
40 |
||
|
|
||||
|
41 |
||||
|
|
|
|||
ITEM 1. |
|
|
41 |
||
|
|
|
|||
ITEM 1A. |
|
|
41 |
||
|
|
|
|||
ITEM 2. |
|
|
41 |
||
|
|
|
|||
ITEM 3. |
|
|
41 |
||
|
|
|
|||
ITEM 4. |
|
|
41 |
||
|
|
|
|||
ITEM 5. |
|
|
41 |
||
|
|
|
|||
ITEM 6. |
|
|
42 |
||
|
|
||||
|
44 |
NOVANTA INC.
(In thousands of U.S. dollars or shares)
(Unaudited)
|
September 29, |
|
|
December 31, |
|
||
|
2017 |
|
|
2016 |
|
||
ASSETS |
|
|
|
|
|
|
|
Current assets |
|
|
|
|
|
|
|
Cash and cash equivalents |
$ |
92,149 |
|
|
$ |
68,108 |
|
Accounts receivable, net of allowance of $782 and $565, respectively |
|
83,008 |
|
|
|
63,769 |
|
Inventories |
|
88,861 |
|
|
|
59,745 |
|
Prepaid income taxes and income taxes receivable |
|
8,107 |
|
|
|
2,058 |
|
Prepaid expenses and other current assets |
|
8,253 |
|
|
|
5,570 |
|
Total current assets |
|
280,378 |
|
|
|
199,250 |
|
Property, plant and equipment, net |
|
60,244 |
|
|
|
35,421 |
|
Deferred tax assets |
|
11,772 |
|
|
|
8,593 |
|
Other assets |
|
4,256 |
|
|
|
12,502 |
|
Intangible assets, net |
|
157,938 |
|
|
|
61,743 |
|
Goodwill |
|
207,720 |
|
|
|
108,128 |
|
Total assets |
$ |
722,308 |
|
|
$ |
425,637 |
|
LIABILITIES, NONCONTROLLING INTEREST AND STOCKHOLDERS’ EQUITY |
|
|
|
|
|
|
|
Current liabilities |
|
|
|
|
|
|
|
Current portion of long-term debt |
$ |
9,115 |
|
|
$ |
7,366 |
|
Accounts payable |
|
39,666 |
|
|
|
32,213 |
|
Income taxes payable |
|
6,086 |
|
|
|
3,969 |
|
Accrued expenses and other current liabilities |
|
40,940 |
|
|
|
26,948 |
|
Total current liabilities |
|
95,807 |
|
|
|
70,496 |
|
Long-term debt |
|
234,188 |
|
|
|
70,554 |
|
Deferred tax liabilities |
|
27,106 |
|
|
|
1,294 |
|
Income taxes payable |
|
4,154 |
|
|
|
5,710 |
|
Other liabilities |
|
15,068 |
|
|
|
18,713 |
|
Total liabilities |
|
376,323 |
|
|
|
166,767 |
|
Commitments and contingencies (Note 13) |
|
|
|
|
|
|
|
Redeemable noncontrolling interest |
|
36,838 |
|
|
|
— |
|
Stockholders’ equity: |
|
|
|
|
|
|
|
Common shares, no par value; Authorized shares: unlimited; Issued and outstanding: 34,583 and 34,458, respectively |
|
423,856 |
|
|
|
423,856 |
|
Additional paid-in capital |
|
32,283 |
|
|
|
30,276 |
|
Accumulated deficit |
|
(127,660 |
) |
|
|
(167,547 |
) |
Accumulated other comprehensive loss |
|
(19,332 |
) |
|
|
(27,715 |
) |
Total stockholders' equity |
|
309,147 |
|
|
|
258,870 |
|
Total liabilities, noncontrolling interest and stockholders’ equity |
$ |
722,308 |
|
|
$ |
425,637 |
|
The accompanying notes are an integral part of these consolidated financial statements.
1
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands of U.S. dollars or shares, except per share amounts)
(Unaudited)
|
Three Months Ended |
|
|
Nine Months Ended |
|
||||||||||
|
September 29, |
|
|
September 30, |
|
|
September 29, |
|
|
September 30, |
|
||||
|
2017 |
|
|
2016 |
|
|
2017 |
|
|
2016 |
|
||||
Revenue |
$ |
146,296 |
|
|
$ |
97,829 |
|
|
$ |
374,372 |
|
|
$ |
285,879 |
|
Cost of revenue |
|
87,589 |
|
|
|
56,617 |
|
|
|
216,082 |
|
|
|
166,279 |
|
Gross profit |
|
58,707 |
|
|
|
41,212 |
|
|
|
158,290 |
|
|
|
119,600 |
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Research and development and engineering |
|
11,659 |
|
|
|
7,961 |
|
|
|
29,878 |
|
|
|
24,029 |
|
Selling, general and administrative |
|
27,724 |
|
|
|
20,972 |
|
|
|
74,666 |
|
|
|
62,357 |
|
Amortization of purchased intangible assets |
|
3,217 |
|
|
|
2,066 |
|
|
|
9,413 |
|
|
|
6,153 |
|
Restructuring, acquisition and divestiture related costs (gain) |
|
3,834 |
|
|
|
(835 |
) |
|
|
6,232 |
|
|
|
5,828 |
|
Total operating expenses |
|
46,434 |
|
|
|
30,164 |
|
|
|
120,189 |
|
|
|
98,367 |
|
Operating income from continuing operations |
|
12,273 |
|
|
|
11,048 |
|
|
|
38,101 |
|
|
|
21,233 |
|
Interest income (expense), net |
|
(2,111 |
) |
|
|
(1,081 |
) |
|
|
(4,874 |
) |
|
|
(3,471 |
) |
Foreign exchange transaction gains (losses), net |
|
(661 |
) |
|
|
188 |
|
|
|
(176 |
) |
|
|
978 |
|
Other income (expense), net |
|
(4 |
) |
|
|
686 |
|
|
|
104 |
|
|
|
1,699 |
|
Gain on acquisition of business |
|
— |
|
|
|
— |
|
|
|
26,409 |
|
|
|
— |
|
Income from continuing operations before income taxes |
|
9,497 |
|
|
|
10,841 |
|
|
|
59,564 |
|
|
|
20,439 |
|
Income tax provision |
|
1,131 |
|
|
|
3,371 |
|
|
|
6,934 |
|
|
|
6,192 |
|
Income from continuing operations |
|
8,366 |
|
|
|
7,470 |
|
|
|
52,630 |
|
|
|
14,247 |
|
Loss from discontinued operations, net of tax |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Consolidated net income |
|
8,366 |
|
|
|
7,470 |
|
|
|
52,630 |
|
|
|
14,247 |
|
Less: Net income attributable to noncontrolling interest |
|
(834 |
) |
|
|
— |
|
|
|
(1,444 |
) |
|
|
— |
|
Net income attributable to Novanta Inc. |
$ |
7,532 |
|
|
$ |
7,470 |
|
|
$ |
51,186 |
|
|
$ |
14,247 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings (loss) per common share from continuing operations (Note 5): |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
$ |
(0.00 |
) |
|
$ |
0.22 |
|
|
$ |
1.15 |
|
|
$ |
0.41 |
|
Diluted |
$ |
(0.00 |
) |
|
$ |
0.21 |
|
|
$ |
1.13 |
|
|
$ |
0.41 |
|
Loss per common share from discontinued operations (Note 5): |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
Diluted |
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
Earnings (loss) per common share attributable to Novanta Inc. (Note 5): |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
$ |
(0.00 |
) |
|
$ |
0.22 |
|
|
$ |
1.15 |
|
|
$ |
0.41 |
|
Diluted |
$ |
(0.00 |
) |
|
$ |
0.21 |
|
|
$ |
1.13 |
|
|
$ |
0.41 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average common shares outstanding—basic |
|
34,833 |
|
|
|
34,677 |
|
|
|
34,809 |
|
|
|
34,689 |
|
Weighted average common shares outstanding—diluted |
|
34,833 |
|
|
|
34,928 |
|
|
|
35,235 |
|
|
|
34,889 |
|
The accompanying notes are an integral part of these consolidated financial statements.
2
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(In thousands of U.S. dollars)
(Unaudited)
|
Three Months Ended |
|
|
Nine Months Ended |
|
||||||||||
|
September 29, |
|
|
September 30, |
|
|
September 29, |
|
|
September 30, |
|
||||
|
2017 |
|
|
2016 |
|
|
2017 |
|
|
2016 |
|
||||
Consolidated net income |
$ |
8,366 |
|
|
$ |
7,470 |
|
|
$ |
52,630 |
|
|
$ |
14,247 |
|
Other comprehensive income (loss): |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency translation adjustments, net of tax (1) |
|
3,311 |
|
|
|
(563 |
) |
|
|
8,340 |
|
|
|
(3,413 |
) |
Pension liability adjustments, net of tax (2) |
|
(45 |
) |
|
|
338 |
|
|
|
43 |
|
|
|
1,633 |
|
Total other comprehensive income (loss) |
|
3,266 |
|
|
|
(225 |
) |
|
|
8,383 |
|
|
|
(1,780 |
) |
Total consolidated comprehensive income (loss) |
|
11,632 |
|
|
|
7,245 |
|
|
|
61,013 |
|
|
|
12,467 |
|
Less: Comprehensive income attributable to noncontrolling interest |
|
(834 |
) |
|
|
— |
|
|
|
(1,444 |
) |
|
|
— |
|
Comprehensive income (loss) attributable to Novanta Inc. |
$ |
10,798 |
|
|
$ |
7,245 |
|
|
$ |
59,569 |
|
|
$ |
12,467 |
|
(1) |
The tax effect on this component of comprehensive income was nominal for all periods presented. |
(2) |
The tax effect on this component of comprehensive income was nominal for all periods presented. See Note 4 for the total amount of pension liability adjustments reclassified out of accumulated other comprehensive income (loss). |
The accompanying notes are an integral part of these consolidated financial statements.
3
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands of U.S. dollars)
(Unaudited)
|
Nine Months Ended |
|
|||||
|
September 29, |
|
|
September 30, |
|
||
|
2017 |
|
|
2016 |
|
||
Cash flows from operating activities: |
|
|
|
|
|
|
|
Consolidated net income |
$ |
52,630 |
|
|
$ |
14,247 |
|
Less: Loss from discontinued operations, net of tax |
|
— |
|
|
|
— |
|
Income from continuing operations |
|
52,630 |
|
|
|
14,247 |
|
Adjustments to reconcile income from continuing operations to net cash provided by operating activities of continuing operations: |
|
|
|
|
|
|
|
Depreciation and amortization |
|
22,440 |
|
|
|
15,317 |
|
Provision for inventory excess and obsolescence |
|
1,837 |
|
|
|
2,387 |
|
Share-based compensation |
|
4,223 |
|
|
|
3,385 |
|
Deferred income taxes |
|
(2,913 |
) |
|
|
162 |
|
Earnings from equity-method investment |
|
(104 |
) |
|
|
(1,698 |
) |
Gain on sale of fixed assets |
|
21 |
|
|
|
(1,736 |
) |
Dividend from equity-method investment |
|
— |
|
|
|
2,341 |
|
Gain on acquisition of business |
|
(26,409 |
) |
|
|
— |
|
Inventory acquisition fair value adjustment |
|
4,754 |
|
|
|
173 |
|
Contingent consideration adjustments |
|
425 |
|
|
|
1,427 |
|
Other |
|
851 |
|
|
|
1,417 |
|
Changes in assets and liabilities which (used)/provided cash, excluding effects from businesses purchased or classified as discontinued operations: |
|
|
|
|
|
|
|
Accounts receivable |
|
(3,859 |
) |
|
|
(3,683 |
) |
Inventories |
|
(11,806 |
) |
|
|
(1,470 |
) |
Prepaid income taxes, income taxes receivable, prepaid expenses and other current assets |
|
(5,806 |
) |
|
|
(3,594 |
) |
Accounts payable, income taxes payable, accrued expenses and other current liabilities |
|
5,975 |
|
|
|
6,110 |
|
Other non-current assets and liabilities |
|
(972 |
) |
|
|
(78 |
) |
Cash provided by operating activities of continuing operations |
|
41,287 |
|
|
|
34,707 |
|
Cash provided by operating activities of discontinued operations |
|
— |
|
|
|
— |
|
Cash provided by operating activities |
|
41,287 |
|
|
|
34,707 |
|
Cash flows from investing activities: |
|
|
|
|
|
|
|
Purchases of property, plant and equipment |
|
(6,502 |
) |
|
|
(7,005 |
) |
Acquisition of businesses, net of cash acquired and working capital adjustments |
|
(168,332 |
) |
|
|
(8,952 |
) |
Proceeds from the sale of property, plant and equipment |
|
44 |
|
|
|
7,037 |
|
Cash used in investing activities of continuing operations |
|
(174,790 |
) |
|
|
(8,920 |
) |
Cash provided by investing activities of discontinued operations |
|
— |
|
|
|
1,498 |
|
Cash used in investing activities |
|
(174,790 |
) |
|
|
(7,422 |
) |
Cash flows from financing activities: |
|
|
|
|
|
|
|
Borrowings under revolving credit facility |
|
176,769 |
|
|
|
— |
|
Repayments of long-term debt and revolving credit facility |
|
(15,625 |
) |
|
|
(14,375 |
) |
Payments for debt issuance costs |
|
(638 |
) |
|
|
(2,496 |
) |
Payments of contingent considerations |
|
(2,546 |
) |
|
|
— |
|
Repurchase of common stock |
|
(370 |
) |
|
|
(1,634 |
) |
Payments of withholding taxes from stock-based awards |
|
(1,846 |
) |
|
|
(1,719 |
) |
Capital lease payments |
|
(646 |
) |
|
|
(905 |
) |
Other financing activities |
|
— |
|
|
|
(1 |
) |
Cash provided by (used in) financing activities of continuing operations |
|
155,098 |
|
|
|
(21,130 |
) |
Cash provided by (used in) financing activities of discontinued operations |
|
— |
|
|
|
— |
|
Cash provided by (used in) financing activities |
|
155,098 |
|
|
|
(21,130 |
) |
Effect of exchange rates on cash and cash equivalents |
|
2,446 |
|
|
|
(1,375 |
) |
Increase in cash and cash equivalents |
|
24,041 |
|
|
|
4,780 |
|
Cash and cash equivalents, beginning of period |
|
68,108 |
|
|
|
59,959 |
|
Cash and cash equivalents, end of period |
$ |
92,149 |
|
|
$ |
64,739 |
|
Supplemental disclosure of cash flow information: |
|
|
|
|
|
|
|
Cash paid for interest |
$ |
3,512 |
|
|
$ |
2,167 |
|
Cash paid for income taxes |
$ |
18,053 |
|
|
$ |
10,870 |
|
Income tax refunds received |
$ |
185 |
|
|
$ |
359 |
|
The accompanying notes are an integral part of these consolidated financial statements.
4
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
AS OF SEPTEMBER 29, 2017
(Unaudited)
1. Basis of Presentation
Novanta Inc. and its subsidiaries (collectively referred to as the “Company”, “Novanta”, “we”, “us”, “our”) is a global supplier of core technology solutions that give healthcare and advanced industrial original equipment manufacturers (“OEMs”) a competitive advantage. Novanta combines deep proprietary technology expertise and competencies in photonics, vision and precision motion with a proven ability to solve complex technical challenges. This enables Novanta to engineer core components and sub-systems that deliver extreme precision and performance, tailored to customers' demanding applications.
The accompanying unaudited interim consolidated financial statements have been prepared in U.S. dollars and pursuant to the rules and regulations of the United States Securities and Exchange Commission (“SEC”), the instructions to Form 10-Q and the provisions of Regulation S-X pertaining to interim financial statements. Accordingly, certain information and footnote disclosures normally included in the financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. The interim consolidated financial statements and notes included in this report should be read in conjunction with the financial statements and notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2016. In the opinion of management, these interim consolidated financial statements include all adjustments and accruals of a normal and recurring nature necessary to fairly state the results of the interim periods presented. The results for interim periods are not necessarily indicative of results to be expected for the full year or for any future periods.
Prior to January 10, 2017, the Company had an approximately 41% ownership interest in Laser Quantum Limited (“Laser Quantum”), a privately held company located in the United Kingdom, which was accounted for under the equity method of accounting. On January 10, 2017, the Company acquired an additional approximately 35% of the outstanding shares of Laser Quantum. As a result of this transaction, the Company’s ownership position in Laser Quantum increased from approximately 41% to approximately 76%. Since January 10, 2017, Laser Quantum has been consolidated in the Company’s consolidated financial statements.
The Company’s unaudited interim financial statements are prepared for each quarterly period ending on the Friday closest to the end of the calendar quarter, with the exception of the fourth quarter which always ends on December 31.
Use of Estimates
The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of revenue and expenses during the reporting periods. The Company evaluates its estimates based on historical experience, current conditions and various other assumptions that it believes are reasonable under the circumstances. Estimates and assumptions are reviewed on an on-going basis and the effects of revisions are reflected in the period in which they are deemed to be necessary. Actual results could differ significantly from those estimates.
5
NOVANTA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)
AS OF SEPTEMBER 29, 2017
(Unaudited)
Recent Accounting Pronouncements
Share-Based Compensation
In May 2017, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) 2017-09, “Compensation – Stock Compensation (Topic 718),” which provides guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting in Topic 718. ASU 2017-09 requires that an entity account for the effects of a modification unless (i) the fair value of the modified award is the same as the fair value of the original award immediately before the original award is modified; (ii) the vesting conditions of the modified award are the same as the vesting conditions of the original award immediately before the original award is modified; and (iii) the classification of the modified award as an equity instrument or a liability instrument is the same as the classification of the original award immediately before the original award is modified. ASU 2017-09 will become effective prospectively for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2017, with early adoption permitted. The Company does not expect the adoption of ASU 2017-09 to have a material impact on its consolidated financial statements.
Presentation of Net Periodic Pension Cost
In March 2017, the FASB issued ASU 2017-07, “Compensation – Retirement Benefits (Topic 715): Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost,” which requires employers that offer or maintain defined benefit plans to disaggregate the service component from the other components of net benefit cost and provides guidance on the presentation of the service component and the other components of net benefit cost in the statement of operations. The new standard is effective for public companies for annual periods beginning after December 15, 2017. The Company expects to adopt the new standard in the first quarter of 2018 and expects to report its net periodic pension cost related to its frozen U.K. pension plan, consisting of interest cost, expected return on plan assets and amortization of actuarial gains (losses) only, in Other income (expense) in the consolidated statement of operations upon adoption.
Goodwill Impairment
In January 2017, the FASB issued ASU 2017-04, “Intangibles – Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment,” which simplifies the accounting for goodwill impairment. The amendment in ASU 2017-04 removes Step-two of the goodwill impairment test, which requires a hypothetical purchase price allocation. ASU 2017-04 will become effective prospectively for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019, with early adoption permitted. The Company is currently evaluating the impact of the new standard on its consolidated financial statements.
Statement of Cash Flows Classification of Certain Cash Receipts and Cash Payments
In August 2016, the FASB issued ASU 2016-15, “Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments.” The standard further clarifies the classification in the cash flow statement of the following items: (i) debt prepayment or debt extinguishment costs; (ii) settlement of zero-coupon debt instruments or other debt instruments with coupon interest rates that are insignificant in relation to the effective interest rate of the borrowing; (iii) contingent consideration payments made after a business combination; (iv) proceeds from the settlement of insurance claims; (v) proceeds from the settlement of corporate-owned life insurance policies, including bank-owned life insurance policies; (vi) distributions received from equity method investees; (vii) beneficial interests in securitization transactions; and (viii) separately identifiable cash flows and application of the predominance principle. ASU 2016-15 will become effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2017, with early adoption permitted. ASU 2016-15 should be applied using a retrospective transition method for each period presented. The Company adopted ASU 2016-15 during the first quarter of 2017. The adoption of ASU 2016-15 resulted in ($2.5) million of payments of contingent considerations being reported as cash used in financing activities on the Company’s consolidated statements of cash flows for the nine months ended September 29, 2017.
Leases
In February 2016, the FASB issued ASU 2016-02, “Leases (Topic 842),” which provides comprehensive lease accounting guidance. The standard requires entities to recognize lease assets and liabilities on the balance sheet and to disclose key information about leasing arrangements. ASU 2016-02 will become effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018, with early adoption permitted. The Company is currently evaluating the potential impact of this
6
NOVANTA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)
AS OF SEPTEMBER 29, 2017
(Unaudited)
guidance and an appropriate implementation strategy. While the Company’s evaluation of this guidance is in the early stages, the Company currently expects adoption of this guidance to have an impact on its consolidated balance sheet.
Revenue from Contracts with Customers
In May 2014, the FASB issued ASU 2014-09, “Revenue from Contracts with Customers (Topic 606),” which provides guidance for revenue recognition. ASU 2014-09 supersedes the revenue recognition requirements in Accounting Standards Codification (“ASC”) 605, “Revenue Recognition (Topic 605),” and requires entities to recognize revenue in a way that depicts the transfer of goods or services to customers at an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. ASU 2014-09 would be effective for annual and interim reporting periods beginning after December 15, 2016 and did not allow early adoption. In August 2015, the FASB issued ASU 2015-14, “Revenue from Contracts with Customers – Deferral of the Effective Date,” which deferred the effective date of ASU 2014-09 by one year to December 15, 2017, with the option of early adoption as of the original effective date. The amendment in ASU 2015-14 resulted in ASU 2014-09 becoming effective for annual and interim reporting periods beginning after December 15, 2017. Upon adoption of Topic 606, an entity may apply the new guidance either retrospectively to each prior reporting period presented (the “full retrospective method”) or retrospectively only to customer contracts not yet completed as of the date of adoption with the cumulative effect of initially applying the standard recognized in beginning retained earnings at the date of the initial application (the “modified retrospective method”).
The Company will adopt the new standard as of January 1, 2018 and has conducted various activities to prepare for the adoption of the new standard. The Company surveyed cross-functional leaders to identify potential revenue streams that could be impacted by Topic 606 and identified certain revenue streams that could be impacted. The Company also reviewed a representative sample of individual customer contracts related to these various revenue streams to determine if the guidance under Topic 606 is expected to have a material impact on revenue recognition.
The Company’s work to date indicates that only a limited number of contracts with customers may require a change in the way revenues are recognized. The Company is still in the process of determining the expected quantitative impact that the adoption of Topic 606 will have on its consolidated financial statements.
The Company concluded that it will adopt the new standard using the modified retrospective method. In addition, the Company will elect to apply certain practical expedients allowed under the guidance. First, the Company does not intend to adjust the promised amount of consideration for the effects of a financing component as the transfer of a promised good to a customer and the customer’s payment for that good are typically expected to be one year or less. Second, the Company will exclude from its transaction price any amounts collected from customers for all sales or other similar taxes, which is consistent with the Company’s current practice. Third, the Company will elect to account for shipping and handling activities that occur after the transfer of control over the related goods as fulfillment activities rather than performance obligations.
2. Business Combinations
WOM
On July 3, 2017, the Company acquired 100% of the outstanding shares of W.O.M. World of Medicine GmbH (“WOM”), a Berlin, Germany-based provider of medical insufflators, pumps, and related disposables for OEMs in the minimally invasive surgical market, for a total purchase price of €118.1 million ($134.9 million), net of working capital adjustments. The acquisition was financed with a €118.0 million ($134.7 million) draw-down on the Company’s revolving credit facility. The Company expects that the addition of WOM will help the Company to better serve customers in minimally invasive surgery applications with a broader range of product offerings. WOM is included in the Company’s Vision reportable segment.
The acquisition of WOM has been accounted for as a business combination. The allocation of the purchase price is based upon a valuation of assets acquired and liabilities assumed. Assets acquired and liabilities assumed have been recorded at their estimated fair values as of the acquisition date. The fair values of intangible assets were based on valuations using an income approach, with estimates and assumptions provided by management of WOM and the Company. The process for estimating the fair values of identifiable intangible assets requires the use of significant estimates and assumptions, including estimating future cash flows and developing appropriate discount rates. The excess of the purchase price over the tangible assets, identifiable intangible assets and assumed liabilities was recorded as goodwill. The Company’s estimates and assumptions in determining the estimated fair values of certain assets and liabilities are subject to change within the measurement period (up to one year from the acquisition date) as a result of additional information obtained with regard to facts and circumstances that existed as of the acquisition date. The purchase price allocation is preliminary as the Company is in the process of collecting additional information for the valuation of inventory, property and equipment, intangible assets, accrued liabilities and unrecognized tax benefits.
7
NOVANTA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)
AS OF SEPTEMBER 29, 2017
(Unaudited)
Based upon a preliminary valuation, the total purchase price allocation is as follows (in thousands):
|
Purchase Price |
|
|
|
Allocation |
|
|
Cash |
$ |
1,400 |
|
Accounts receivable |
|
11,807 |
|
Inventories |
|
14,549 |
|
Property and equipment |
|
21,940 |
|
Intangible assets |
|
59,732 |
|
Goodwill |
|
53,775 |
|
Other assets |
|
2,660 |
|
Total assets acquired |
|
165,863 |
|
Accounts payable |
|
4,398 |
|
Other liabilities |
|
8,276 |
|
Deferred tax liabilities |
|
18,255 |
|
Total liabilities assumed |
|
30,929 |
|
Total assets acquired, net of liabilities assumed |
|
134,934 |
|
Less: cash acquired |
|
1,400 |
|
Total purchase price, net of cash acquired |
$ |
133,534 |
|
The fair value of intangible assets is comprised of the following (dollar amounts in thousands):
|
|
|
|
|
Weighted Average |
|
Estimated Fair |
|
|
Amortization |
|
|
Value |
|
|
Period |
|
Developed technologies |
$ |
21,586 |
|
|
10 years |
Customer relationships |
|
34,949 |
|
|
12 years |
Trademarks and trade names |
|
2,284 |
|
|
10 years |
Backlog |
|
913 |
|
|
1 year |
Total |
$ |
59,732 |
|
|
|
The purchase price allocation resulted in $59.7 million of identifiable intangible assets and $53.8 million of goodwill. As the WOM acquisition is an acquisition of outstanding common shares, none of the resulting goodwill is deductible for tax purposes. Intangible assets are being amortized over their weighted average useful lives primarily based upon the pattern in which anticipated economic benefits from such assets are expected to be realized. The goodwill recorded represents the anticipated incremental value of future cash flows potentially attributable to: (i) WOM’s ability to grow its business with existing and new customers, including leveraging the Company’s customer base; and (ii) cost improvements due to expansion in scale.
The operating results of WOM were included in the Company’s results of operations beginning on July 3, 2017. WOM contributed revenues of $24.8 million and an operating loss from continuing operations before income taxes of $1.6 million for the nine months ended September 29, 2017. Operating loss from continuing operations before income taxes for the nine months ended September 29, 2017 included amortization of inventory fair value adjustments and amortization of purchased intangible assets of $4.9 million.
ThingMagic
On January 10, 2017, the Company acquired from Trimble Inc. certain assets and liabilities that constituted the business of ThingMagic, a Woburn, Massachusetts-based provider of ultra-high frequency (“UHF”) radio frequency identification (“RFID”) modules and finished RFID readers to OEMs in the medical and advanced industrial markets, for a total purchase price of $19.1 million, net of working capital adjustments. The acquisition was financed with cash on hand and a $12.0 million draw-down on the Company’s revolving credit facility. The Company expects that the addition of ThingMagic will broaden its portfolio of RFID
8
NOVANTA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)
AS OF SEPTEMBER 29, 2017
(Unaudited)
solutions, while providing the resources to address the growing need for improvements in workflow solutions, patient safety, anti-counterfeiting, and asset tracking in a medical environment. ThingMagic is included in the Company’s Vision reportable segment.
The acquisition of ThingMagic has been accounted for as a business combination. The allocation of the purchase price is based upon a valuation of assets and liabilities acquired. Assets acquired and liabilities assumed have been recorded at their estimated fair values as of the acquisition date. The fair values of intangible assets were based on valuations using an income approach, with estimates and assumptions provided by management of ThingMagic and the Company. The process for estimating the fair values of identifiable intangible assets requires the use of significant estimates and assumptions, including estimating future cash flows and developing appropriate discount rates. The excess of the purchase price over the tangible assets, identifiable intangible assets and assumed liabilities was recorded as goodwill. The Company’s estimates and assumptions in determining the estimated fair values of certain assets and liabilities are subject to change within the measurement period (up to one year from the acquisition date) as a result of additional information obtained with regards to facts and circumstances that existed as of the acquisition date.
Based upon a preliminary valuation, the total purchase price was allocated as follows (in thousands):
|
Purchase Price |
|
|
|
Allocation |
|
|
Inventories |
$ |
1,832 |
|
Intangible assets |
|
7,423 |
|
Goodwill |
|
9,929 |
|
Total assets acquired |
|
19,184 |
|
|
|
|
|
Other liabilities |
|
95 |
|
Total liabilities assumed |
|
95 |
|
Total purchase price |
$ |
19,089 |
|
The fair value of intangible assets is comprised of the following (dollar amounts in thousands):
|
|
|
|
|
Weighted Average |
|
Estimated Fair |
|
|
Amortization |
|
|
Value |
|
|
Period |
|
Developed technologies |
$ |
4,600 |
|
|
10 years |
Customer relationships |
|
2,520 |
|
|
10 years |
Trademarks and trade names |
|
303 |
|
|
5 years |
Total |
$ |
7,423 |
|
|
|
The purchase price allocation resulted in $7.4 million of identifiable intangible assets and $9.9 million of goodwill. As the ThingMagic acquisition is treated as an acquisition of assets for income tax purposes, the goodwill acquired is expected to be fully deductible. Intangible assets are being amortized over their weighted average useful lives primarily based upon the pattern in which anticipated economic benefits from such assets are expected to be realized. The goodwill recorded represents the anticipated incremental value of future cash flows potentially attributable to: (i) ThingMagic’s ability to grow its business with existing and new customers, including leveraging the Company’s customer base; (ii) cost synergies in combining the research and development capabilities from ThingMagic with the existing RFID capabilities within Novanta; and (iii) cost improvements due to the integration of ThingMagic operations into the Company’s existing infrastructure.
The operating results of ThingMagic were included in the Company’s results of operations beginning on January 10, 2017. ThingMagic contributed revenues of $6.5 million and operating income from continuing operations before income taxes of $0.1 million for the nine months ended September 29, 2017. Operating income from continuing operations before income taxes for the nine months ended September 29, 2017 included amortization of inventory fair value adjustments and amortization of purchased intangible assets of $1.2 million.
The pro forma financial information reflecting the operating results of ThingMagic, as if it had been acquired as of January 1, 2016, would not differ materially from the operating results of the Company as reported for the year ended December 31, 2016.
9
NOVANTA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)
AS OF SEPTEMBER 29, 2017
(Unaudited)
On January 10, 2017, the Company acquired an additional approximately 35% of the outstanding shares of Laser Quantum, a Manchester, United Kingdom-based provider of solid state continuous wave lasers, femtosecond lasers, and optical light engines to OEMs in the medical market, for £25.5 million ($31.1 million) in cash consideration. The purchase price was financed with cash on hand and a $30.0 million draw-down on the Company’s revolving credit facility. As a result of this transaction, the Company’s ownership position in Laser Quantum increased from approximately 41% to approximately 76%. By establishing control through a majority equity ownership, the Company expects to broaden its technology capability in photonics solutions for medical applications, particularly within the growing DNA sequencing market, while providing key enabling photonics-based technologies for instrumentation and life science applications such as biomedical imaging, cell sorting, and ophthalmology. Laser Quantum is included in the Company’s Photonics reportable segment.
As part of this transaction, the Company and the remaining shareholders of Laser Quantum entered into a call and put option agreement for the purchase and sale, in 2020, of all remaining Laser Quantum shares held by the other shareholders, subject to certain conditions. The purchase price for the remaining shares will be based on the proportionate share of the noncontrolling interest (“NCI”) in Laser Quantum’s cash on hand as of December 31, 2019 and a multiple of Laser Quantum’s EBITDA for the twelve months ending December 31, 2019, as defined in the call and put option agreement.
In connection with the purchase price allocation, upon gaining control over Laser Quantum, the Company recognized a nontaxable gain of $26.4 million in the consolidated statement of operations for the nine months ended September 29, 2017. The gain represented the excess of the fair value of the Company’s previously-held equity interest in Laser Quantum over its carrying value upon gaining control.
The fair value of the approximately 41% equity interest previously held by the Company before the acquisition and the fair value of the approximately 24% NCI held by the remaining shareholders of Laser Quantum after the acquisition were determined using a combination of the discounted cash flow method (an income approach), the guideline public company method (a market approach), and the subject company transaction method (a market approach). The subject company transaction method was based on the purchase price paid by the Company for the acquisition of the additional approximately 35% of the outstanding shares, while giving consideration to the control and/or minority nature of the subject equity interests.
The acquisition of Laser Quantum has been accounted for as a business combination. The allocation of the purchase price is based upon a valuation of assets and liabilities acquired. Assets acquired and liabilities assumed have been recorded at their estimated fair values as of the acquisition date. The fair values of intangible assets were based on valuations using an income approach, with estimates and assumptions provided by management of Laser Quantum and the Company. The process for estimating the fair values of identifiable intangible assets requires the use of significant estimates and assumptions, including estimating future cash flows and developing appropriate discount rates. The excess of the purchase price over the tangible assets, identifiable intangible assets and assumed liabilities was recorded as goodwill. The Company’s estimates and assumptions in determining the estimated fair values of certain assets and liabilities are subject to change within the measurement period (up to one year from the acquisition date) as a result of additional information to be obtained with regards to facts and circumstances that existed as of the acquisition date.
Based upon a preliminary valuation, the total purchase price was allocated as follows (in thousands):
10
NOVANTA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)
AS OF SEPTEMBER 29, 2017
(Unaudited)
Purchase Price |
|
||
|
Allocation |
|
|
Cash |
$ |
15,343 |
|
Accounts receivable |
|
2,739 |
|
Inventories |
|
6,264 |
|
Property and equipment |
|
2,286 |
|
Intangible assets |
|
38,955 |
|
Goodwill |
|
31,041 |
|
Other assets |
|
717 |
|
Total fair value of assets |
|
97,345 |
|
|
|
|
|
Accounts payable |
|
796 |
|
Other liabilities |
|
2,068 |
|
Deferred tax liabilities |
|
7,210 |
|
Total fair value of liabilities |
|
10,074 |
|
Total fair value of assets, net of fair value of liabilities |
|
87,271 |
|
Less: fair value of equity interest previously held by Novanta |
|
34,637 |
|
Less: fair value of noncontrolling interest |
|
21,582 |
|
Total purchase price paid by Novanta |
|
31,052 |
|
Less: cash acquired |
|
15,343 |
|
Purchase price, net of cash acquired |
$ |
15,709 |
|
The fair value of intangible assets is comprised of the following (dollar amounts in thousands):
|
|
|
|
|
Weighted Average |
|
Estimated Fair |
|
|
Amortization |
|
|
Value |
|
|
Period |
|
Developed technologies |
$ |
15,501 |
|
|
15 years |
Customer relationships |
|
19,990 |
|
|
15 years |
Trademarks and trade names |
|
1,964 |
|
|
15 years |
Backlog |
|
1,500 |
|
|
9 months |
Total |
$ |
38,955 |
|
|
|
The purchase price allocation resulted in $39.0 million of identifiable intangible assets and $31.0 million of goodwill. As the Laser Quantum acquisition is an acquisition of outstanding common shares, none of the resulting goodwill is deductible for tax purposes. Intangible assets are being amortized over their weighted average useful lives primarily based upon the pattern in which anticipated economic benefits from such assets are expected to be realized. The goodwill recorded represents the anticipated incremental value of future cash flow potential attributable to: (i) Laser Quantum’s ability to grow its business with existing and new customers, including leveraging the Company’s broader customer base; and (ii) cost improvements due to expansion in scale.
The operating results of Laser Quantum were included in the Company’s results of operations beginning on January 10, 2017. Laser Quantum contributed revenues of $32.3 million and income from continuing operations before income taxes of $7.0 million for the nine months ended September 29, 2017. Operating income from continuing operations before income taxes for the nine months ended September 29, 2017 included $5.8 million of expenses associated with the amortization of inventory fair value step-up and purchased intangible assets.
Unaudited Pro Forma Information
The pro forma information for all periods presented below includes the effects of business combination accounting resulting from the acquisitions of WOM and Laser Quantum, including amortization of inventory fair value adjustments, amortization of intangible assets, interest expense on borrowings in connection with the acquisition, elimination of the gain from business acquisition and income from equity method investment, and the related tax effects as though the acquisitions had been consummated as of
11
NOVANTA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)
AS OF SEPTEMBER 29, 2017
(Unaudited)
January 1, 2016. The pro forma financial information is presented for comparative purposes only and is not necessarily indicative of the results of operations that actually would have been achieved if the acquisitions had taken place on January 1, 2016.
|
Three Months Ended |
|
|
Nine Months Ended |
|
||||||||||
|
September 29, |
|
|
September 30, |
|
|
September 29, |
|
|
September 30, |
|
||||
|
2017 |
|
|
2016 |
|
|
2017 |
|
|
2016 |
|
||||
Revenue |
$ |
146,296 |
|
|
$ |
124,925 |
|
|
$ |
415,900 |
|
|
$ |
361,701 |
|
Income from continuing operations |
$ |
12,727 |
|
|
$ |
8,241 |
|
|
$ |
32,038 |
|
|
$ |
12,804 |
|
Earnings per common share attributable to Novanta Inc. - Basic |
$ |
0.12 |
|
|
$ |
0.24 |
|
|
$ |
0.55 |
|
|
$ |
0.36 |
|
Earnings per common share attributable to Novanta Inc. - Diluted |
$ |
0.12 |
|
|
$ |
0.24 |
|
|
$ |
0.55 |
|
|
$ |
0.36 |
|
Acquisition Costs
Acquisition-related costs are included in restructuring, acquisition and divestiture related costs in the consolidated statements of operations. Acquisition-related costs for WOM, ThingMagic and Laser Quantum are as follows (in thousands):
|
Three Months Ended |
|
|
Nine Months Ended |
|
||
|
September 29, |
|
|
September 29, |
|
||
|
2017 |
|
|
2017 |
|
||
ThingMagic |
$ |
— |
|
|
$ |
149 |
|
Laser Quantum |
$ |
— |
|
|
$ |
264 |
|
WOM |
$ |
3,359 |
|
|
$ |
4,351 |
|
3. Discontinued Operations and Divestitures
In July 2014, the Company completed the sale of certain assets and liabilities of its Scientific Lasers business for approximately $6.5 million in cash, net of working capital adjustments. In accordance with the purchase and sale agreement, $1.5 million of the sales proceeds was held in escrow until January 2016. In January 2016, the $1.5 million escrow was released to the Company in full and is reported as cash flow from investing activities of discontinued operations.
4. Accumulated Other Comprehensive Income (Loss)
Changes in accumulated other comprehensive income (loss) was as follows (in thousands):
|
Total accumulated |
|
|
|
|
|
|
|
|
|
|
|
other |
|
|
Foreign currency |
|
|
|
|
|
||
|
comprehensive |
|
|
translation |
|
|
Pension |
|
|||
|
income (loss) |
|
|
adjustments |
|
|
liabilities |
|
|||
Balance at December 31, 2016 |
$ |
(27,715 |
) |
|
$ |
(17,222 |
) |
|
$ |
(10,493 |
) |
Other comprehensive income (loss) |
|
7,509 |
|
|
|
8,340 |
|
|
|
(831 |
) |
Amounts reclassified from other comprehensive income (loss) (1) |
|
874 |
|
|
|
— |
|
|
|
874 |
|
Balance at September 29, 2017 |
$ |
(19,332 |
) |
|
$ |
(8,882 |
) |
|
$ |
(10,450 |
) |
|
(1) |
The amounts reclassified from other comprehensive income (loss) were included in selling, general and administrative expenses in the consolidated statements of operations. |
5. Earnings (Loss) per Common Share
Basic earnings (loss) per common share is computed by dividing net income attributable to Novanta Inc. after adjustment of redeemable noncontrolling interest to estimated redemption value by the weighted average number of common shares outstanding
12
NOVANTA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)
AS OF SEPTEMBER 29, 2017
(Unaudited)
during the period. The Company recognizes changes in the redeemable noncontrolling interest redemption value by adjusting the carrying amount of the redeemable noncontrolling interest as of the end of the period to the higher of: (i) the estimated redemption value assuming the end of the period is also the redemption date or (ii) the carrying value without any redemption value adjustments. Such adjustments are recorded in retained earnings in stockholders’ equity instead of net income attributable to Novanta Inc. For both basic and diluted earnings (loss) per common share, such redemption value adjustments are included in the calculation of the numerator. For diluted earnings (loss) per common share, the denominator also includes the dilutive effect of outstanding restricted stock units, stock options and total shareholder return performance restricted stock units determined using the treasury stock method. Dilutive effects of contingently issuable shares are included in the weighted average dilutive share calculation using the treasury stock method when the contingencies have been resolved. For periods in which net losses are generated, the dilutive potential common shares are excluded from the calculation of diluted earnings per common share as the effect would be anti-dilutive.
The following table sets forth the computation of basic and diluted earnings (loss) per common share (in thousands, except per share amounts):
|
Three Months Ended |
|
|
Nine Months Ended |
|
||||||||||
|
September 29, |
|
|
September 30, |
|
|
September 29, |
|
|
September 30, |
|
||||
|
2017 |
|
|
2016 |
|
|
2017 |
|
|
2016 |
|
||||
Numerators: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations |
$ |
8,366 |
|
|
$ |
7,470 |
|
|
$ |
52,630 |
|
|
$ |
14,247 |
|
Less: Net income attributable to noncontrolling interest |
|
(834 |
) |
|
|
— |
|
|
|
(1,444 |
) |
|
|
— |
|
Net income attributable to Novanta Inc. |
|
7,532 |
|
|
|
7,470 |
|
|
|
51,186 |
|
|
|
14,247 |
|
Less: Adjustment of redeemable noncontrolling interest to estimated redemption value (see Note 14) |
|
(7,585 |
) |
|
|
— |
|
|
|
(11,303 |
) |
|
|
— |
|
Net income (loss) attributable to Novanta Inc. after adjustment of redeemable noncontrolling interest to estimated redemption value |
$ |
(53 |
) |
|
$ |
7,470 |
|
|
$ |
39,883 |
|
|
$ |
14,247 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Denominators: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average common shares outstanding— basic |
|
34,833 |
|
|
|
34,677 |
|
|
|
34,809 |
|
|
|
34,689 |
|
Dilutive potential common shares (1) |
|
— |
|
|
|
251 |
|
|
|
426 |
|
|
|
200 |
|
Weighted average common shares outstanding— diluted |
|
34,833 |
|
|
|
34,928 |
|
|
|
35,235 |
|
|
|
34,889 |
|
Antidilutive common shares excluded from above |
|
— |
|
|
|
144 |
|
|
|
— |
|
|
|
112 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic Earnings (Loss) per Common Share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic earnings (loss) per common share attributable to Novanta Inc. |